FBK: Growth is solid, but credit and valuation set a higher bar
FBK Premium research: growth is solid, but credit and valuation set a higher bar.
Stocks
C: Returns are improving, but the next proof point is close
C Premium research: returns are improving, but the next proof point is close.
BLK: A three-path earnings sensitivity ahead of results
BLK Premium research: three earnings paths ahead of October results.
JNJ: Quality and valuation meet an October test
JNJ Premium research: current guidance and valuation meet an October results test.
LW: Earnings conversion faces an October test
LW Premium research: earnings conversion faces an October test.
MAT: Leadership reset meets an operating test
MAT Premium research: leadership reset meets an operating test.
SNPS: Strategic proof meets a demanding valuation
SNPS Premium research.
KOD: Clinical de-risking meets a demanding valuation
Kodiak Sciences cleared an important Phase 3 hurdle, while its filing plan and sharp repricing make regulatory execution the central question.
FORM: Operating momentum meets valuation gravity
FormFactor has paired faster growth with a sharp margin recovery, while the October 1 market price already discounts substantial continuation.
APLD: The conversion test arrives
APLD Premium research.